Wai Chun Bio-Technology (HKSE:00660) ROCE %: 0.00% (As of Dec. 2025)

What is Wai Chun Bio-Technology ROCE %?

Wai Chun Bio-Technology HKSE:00660 -4.00% 17 ROCE % is 0.00% as of Dec. 2025. GuruFocus rates HKSE:00660 with a GF Score™ of 17/100 and a GF Value™ of HK$0.13 (Significantly Overvalued). The stock has 7 warning signs investors should review.

ROCE % measures how well a company generates profits from its capital. It is calculated as EBIT divided by Capital Employed, where Capital Employed is calculated as Total Assets minus Total Current Liabilities. Wai Chun Bio-Technology's annualized ROCE % for the quarter that ended in Dec. 2025 was 0.00%.

Wai Chun Bio-Technology (HKSE:00660) ROCE % Explanation

ROCE % can be especially useful when comparing the performance of capital-intensive companies. Unlike ROE %, which indicates the profitability of Shareholders Equity, ROCE % also considers long-term debt in Capital Employed. This can be helpful when analyzing companies with significant debt, as the result is neutralized by taking debt into consideration.

Generally speaking, a higher ROCE % indicates a stonger profitability for a company. Moreover, it is important to look at the ratio from a long term perspective. Investors tend to favor companies with stable and rising ROCE % trend over those with volatile ones.

Wai Chun Bio-Technology ROCE % Related Terms

Wai Chun Bio-Technology ROCE % Historical Data

* Premium members only.

The historical data trend for Wai Chun Bio-Technology's ROCE % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Wai Chun Bio-Technology ROCE % Chart

Wai Chun Bio-Technology Annual Data

Trend

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Jun22

Jun23

Jun24

Jun25

ROCE %

Get a 7-Day Free Trial

4.76

0.00

14.91

-325.25

0.00

Wai Chun Bio-Technology Semi-Annual Data
	Jun16	Dec16	Jun17	Dec17	Jun18	Dec18	Jun19	Dec19	Jun20	Dec20	Jun21	Dec21	Jun22	Dec22	Jun23	Dec23	Jun24	Dec24	Jun25	Dec25
ROCE %	Get a 7-Day Free Trial															14.29	-635.23	0.00	0.00	0.00

17GF Score

Wai Chun Bio-Technology Ltd HKSE:00660

ROCE % is just one metric. See GF Score™, valuation, warning signs, and more.

View Full Analysis

Wai Chun Bio-Technology ROCE % Calculation

Wai Chun Bio-Technology's annualized ROCE % for the fiscal year that ended in Jun. 2025 is calculated as:

ROCE %	=	EBIT	/	( (Capital Employed	+	Capital Employed)	/ count )
		(A: Jun. 2025 )		(A: Jun. 2024 )		(A: Jun. 2025 )
	=	EBIT	/	( ( (Total Assets - Total Current Liabilities)	+	(Total Assets - Total Current Liabilities) )	/ count )
		(A: Jun. 2025 )		(A: Jun. 2024 )		(A: Jun. 2025 )
	=	4.721	/	( ( (209.498 - 253.847)	+	(214.655 - 277.308) )	/ 2 )
	=	4.721	/	( (-44.349	+	-62.653)	/ 2 )
	=	4.721	/	-53.501
	=	-8.82 %

Wai Chun Bio-Technology's ROCE % of for the quarter that ended in Dec. 2025 is calculated as:

ROCE %	=	EBIT ⁽¹⁾	/	( (Capital Employed	+	Capital Employed)	/ count )
		(Q: Dec. 2025 )		(Q: Jun. 2025 )		(Q: Dec. 2025 )
	=	EBIT	/	( ( (Total Assets - Total Current Liabilities)	+	(Total Assets - Total Current Liabilities) )	/ count )
		(Q: Dec. 2025 )		(Q: Jun. 2025 )		(Q: Dec. 2025 )
	=	3.448	/	( ( (214.655 - 277.308)	+	(226.345 - 182.668) )	/ 2 )
	=	3.448	/	( ( -62.653	+	43.677 )	/ 2 )
	=	3.448	/	-9.488
	=	0 %

(1) Note: The EBIT data used here is two times the semi-annual (Dec. 2025) EBIT data.

Frequently Asked Questions Learn more about ROCE % →

What does a ROCE % of 0.00% mean?

Wai Chun Bio-Technology (HKSE:00660) has a ROCE % of 0.00% as of Dec. 2025.

Is Wai Chun Bio-Technology's ROCE % too high?

Wai Chun Bio-Technology's current ROCE % is 0.00%. Overall, Wai Chun Bio-Technology has a GF Score™ of 17/100 and is considered Significantly Overvalued, reflecting its overall financial health beyond just this single metric.

How does Wai Chun Bio-Technology's ROCE % compare to DOW?

Wai Chun Bio-Technology's ROCE % of 0.00% can be compared against companies in the Chemicals industry. The industry median ROCE % is 6.42. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.

What is a good ROCE % for a Chemicals company?

The median ROCE % among Chemicals companies is 6.42, based on 1,595 companies in the industry. Companies in the top quartile (top 25%) have a ROCE % significantly above this median, while those in the bottom quartile fall well below. However, ROCE % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.

What does a high ROCE % mean?

A high ROCE % can signal that a stock is expensive relative to its fundamentals. For the Chemicals industry, the median ROCE % is 6.42 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Wai Chun Bio-Technology's current ROCE % is 0.00%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.

Is Wai Chun Bio-Technology stock overvalued right now?

Based on GuruFocus' analysis, Wai Chun Bio-Technology (HKSE:00660) is currently considered Significantly Overvalued. The stock's GF Value™ is HK$0.13, compared to a current price of HK$0.48 — trading 269.2% above its estimated fair value. The current ROCE % is 0.00%. Wai Chun Bio-Technology's overall GF Score™ is 17/100 with 7 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.

How is ROCE % calculated?

ROCE % is calculated from a company's financial statements. For Wai Chun Bio-Technology (HKSE:00660), the current ROCE % is 0.00% as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Wai Chun Bio-Technology (HKSE:00660) Overvalued in 2026?

Based on GuruFocus' analysis, Wai Chun Bio-Technology stock appears to be overvalued. The current stock price of HK$0.48 is trading 269.2% above its estimated GF Value™ of HK$0.13. GuruFocus considers Wai Chun Bio-Technology to be Significantly Overvalued.

Key valuation signals for HKSE:00660:

ROCE %: 0.00%
GF Value™: HK$0.13 vs. price of HK$0.48 (269.2% above fair value)
GF Score™: 17/100 with 7 warning signs

No single metric tells the full story. See the HKSE:00660 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Wai Chun Bio-Technology Business Description

Industry Basic Materials Chemicals

Comparable Companies HKSE:00827 HKSE:08139 HKSE:02881 HKSE:00609 HKSE:01702 HKSE:00433 TSE:4063 XTER:BAS SAU:2010 SHSE:600989 DOW TSE:4004 SZSE:002460 XKRX:051910 SZSE:000408 SHSE:600346 SZSE:002080 TSE:4091 SZSE:002493 SHSE:600160

Address 26 Harbour Road, Rooms 4001-02, 40th Floor, China Resources Building, Wanchai, Hong Kong, HKG

Website http://www.0660.hk

Wai Chun Bio-Technology Ltd is an investment holding company. The company has one reportable segmentbeing the manufacturing and sale of modified starch and other biochemical products. It is involved in the manufacturing and sale of modified starch and other biochemical products. Geographically, it derives a majority of its revenue from the People's Republic of China. The company also has its presence in Hong Kong.

17GF Score

Get the complete analysis for HKSE:00660

ROCE % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

HK$0.48

Price

HK$0.13

GF Value

View HKSE:00660 Analysis

See ROCE % data for all stocks →